Deterrents to Immediate Antiretroviral Therapy Initiation by Pregnant Women Living with HIV in Hhohho Region, Swaziland

Harriet T Mamba, Khumbulani W Hlongwana


Despite robust evidence that immediate antiretroviral therapy (ART) initiation reduces transmission of HIV from mother to child, some pregnant women living with HIV in sub-Saharan Africa (SSA), and Swaziland in particular, continue to refuse ART. This study explored the reasons which deter pregnant women living with HIV from immediate ART initiation in the Hhohho region, Swaziland, using grounded theory design. In-depth interviews with ten purposively selected pregnant women who refused immediate ART initiation were carried out in three high volume health facilities. The thematic analysis revealed key reasons that deterred women from immediate ART initiation. These were shock and perceived stigma, participants‘ conceptualisation of health and ART and the fear of ART and its side effects. The study offers qualitative evidence from Swaziland that might help illuminate issues that prevent pregnant women from accepting immediate ART initiation for their own health and that of their children. The evidence generated from this study can be used for developing targeted and culturally appropriate intervention strategies for Swazi women. (Afr J Reprod Health 2018; 22[4]: 72-80).

Full Text:



HIV/AIDS JUNPO. Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations political declaration on HIV and AIDS. AIDS. 2014.

Meyers K, Qian H, Wu Y, Lao Y, Chen Q,Dong X, Li H, Yang Y, Jiang C and Zhou Z. Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China. PLoS ONE. 2015; 10: e0138104.


UNAIDS/JC2910E. 2017.

Vrazo AC, Sullivan D and Ryan PB . Eliminating Mother-to-Child Transmission of HIV by 2030: 5 Strategies to Ensure Continued Progress. Global Health: Science and Practice. 2018; 6: 249-56.

Duff P, Kipp W, Wild TC, Rubaale T and Okech-Ojony J. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. Journal of the International AIDS Society. 2010; 13: 37.

Eaton JW, Rehle TM, Jooste S, Nkambule R, Kim AA, Mahy M and Hallett TB . Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS. 2014; 28: S507-S14.

World Health Organization. Global Health Sector Strategy on HIV, 2016–2021. Draft for consultation. 2015.

Mofenson LM. New challenges in the elimination of pediatric HIV infection: the expanding population of HIV-exposed but uninfected children. Clinical Infectious Diseases. 2015: civ064.

World Health Organization. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. World Health Organization, 2015.

Ahmed S, Kim MH and Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Current opinion in HIV and AIDS. 2013; 8: 474-89.

HIV/AIDS JUNPO. The gap report. Geneva: UNAIDS; 2014. 4/2014gapreport/gapreport [accessed 23 March 2017].

Granich R, Gupta S, Hersh B, Williams B, Montaner J, Young B and Zunga JM. Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990–2013. PLoS ONE. 2015; 10: e0131353.

Black S, Zulliger R, Marcus R, Mark D, Myer L and Bekker LG. Acceptability and challenges of rapid ART initiation among pregnant women in a pilot programme, Cape Town, South Africa. AIDS Care. 2014; 26: 736-41.

Ferguson L, Grant AD, Watson-Jones D, Kahawita T, Ong'ech JO and Ross DA. Linking women who test HIV-positive in pregnancy-related services to long-term HIV care and treatment services: a systematic review. Conectando a las mujeres con una prueba positiva de VIH durante el embarazo a los servicios de larga duración de cuidados y tratamiento para VIH: revisión sistemática. 2012; 17: 564-80.

Swaziland MoH. ANNUAL HIV PROGRAMS REPORT, Mbabane 2015.

Ministry of Health. Integrated Comprehensive HIV guidelines. In: Health Mo, (ed.). 2015 ed. Mbabane: Swaziland National AIDS program, 2015.

Gourlay A, Birdthistle I, Mburu G, Iorpenda K and Wringe A. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review. Journal of the International AIDS Society. 2013; 16.

Ministry of Health Swaziland. PMTCT Report. In: Unit AsrH, (ed.). 2017.

Central Statistics Office Swaziland. Multiple indicator cluster survey. Mbabane ,Swaziland: United Nations children's fund, 2016.

Patton M. Qualitative Research and Evaluation Methods, 209-339. Thousand Oaks, CA: Sage. Un estudio cualitativo, 2002.

Polit DF and Beck CT. Nursing research: Generating and assessing evidence for nursing practice. Lippincott Williams & Wilkins, 2008.

Ulin PR, Robinson ET and Tolley E. Qualitative methods in public health. Med Sci Sports Exerc. 2005; 37: 1249.

Patton MQ. Qualitative evaluation and research methods. SAGE Publications, inc, 1990: 1204-1206,.

Quinn PM. Qualitative research and evaluation methods. California EU: Sage Publications Inc. 2002:128-129.

Neuman LW. Social research methods: Qualitative and quantitative approaches. 2002.

Hennink MM, Kaiser BN and Marconi VC. Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough? Qual Health Res. 2017; 27: 591-608.

Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B, Burroughs H and Jinks C. Saturation in qualitative research: exploring its conceptualization and operationalization. Quality & Quantity. 1-15.

World Health Organization. WHO Country Cooperation Strategy at a Glance: Benin. 2015.

World Health Organization. Global health sector strategy on HIV 2016-2021. Towards ending AIDS. 2016.

Katirayi L, Namadingo H, Phiri M, Bobrow EA, Ahimbisibwe A, Berhan AY, Buono N, Moland KM and Tylleskär T. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study. Journal of the International AIDS Society. 2016; 19.

Stinson K and Myer L. Barriers to initiating antiretroviral therapy during pregnancy: a qualitative study of women attending services in Cape Town, South Africa. African Journal of AIDS research. 2012; 11: 65-73.

Ngarina M, Tarimo EAM, Naburi H, Kilewo C, Mwanyika-Sando M, Chalamilla G, Biberfeld G and Ekstrom AM. Women's Preferences Regarding Infant or Maternal Antiretroviral Prophylaxis for Prevention of Mother-To-Child Transmission of HIV during Breastfeeding and Their Views on Option B+ in Dar es Salaam, Tanzania. PLoS ONE. 2014; 9: e85310.

HIV/AIDS UJUNPO. Ending AIDS Progress towards the

–90–90 targets. 2017.

Buregyeya E, Naigino R, Mukose A, Makumbi F, Esiru G, Arinaitwe J, Musinguzi J and Wanyenze RK. Facilitators and barriers to uptake and adherence to lifelong antiretroviral therapy among HIV infected pregnant women in Uganda: a qualitative study. BMC Pregnancy and Childbirth. 2017; 17: 94.

Govindasamy D, Ford N and Kranzer K. Risk factors, barriers and facilitators for linkage to antiretroviral therapy care: a systematic review. Aids. 2012; 26: 2059-67.

Iroezi ND, Hoffman RM, Mindry D, Kawale P, Chikowi G and Jansen PA. A qualitative analysis of the barriers and facilitators to receiving care in a prevention of mother-to-child program in Nkhoma, Malawi: original research article. African journal of reproductive health. 2013; 17: 118-29.

Kim MH, Zhou A, Mazenga, Ahmed S, Markham C, Zomba G, Simon K ,Kazembe PN and Abrams EJ. Why Did I Stop? Barriers and Facilitators to Uptake and Adherence to ART in Option B+ HIV Care in Lilongwe, Malawi. PLoS ONE. 2016; 11.

Clouse K, Pettifor A, Shearer K, Maskew M, Bassett J, Larson B, Van Rie A and Fox MP. Loss to follow‐ up before and after delivery among women testing HIV positive during pregnancy in Johannesburg, South Africa. Tropical Medicine & International Health. 2013; 18: 451-60.

Theilgaard ZP, Katzenstein TL, Chiduo MG, Pahl C, Gerstoft J, Lemnge MM and Tersbol BT. Addressing the fear and consequences of stigmatization-a necessary step towards making HAART accessible to women in Tanzania: a qualitative study. AIDS research and therapy. 2011; 8: 28.

Tweya H, Gugsa S, Hosseinipour M, Speight C, Ng'ambi W, Bokosi M, Chikonda J, Chauma A, Khomani P, Phoso M, Mtande T and Phiri S. Understanding factors, outcomes and reasons for loss to follow‐up among women in Option B+ PMTCT programme in Lilongwe, Malawi. Tropical Medicine & International Health. 2014; 19: 1360-6.

The Ministry of Health, Swaziland, United Nations Population Fund. Socio - Cultural Factors Influencing ASRH Service Utilization. 2016: 69.


  • There are currently no refbacks.